SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2xt0'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BSX_A_T3A1_1
(PROTEIN (THYROID
HORMONE RECEPTOR
BETA))
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
5 / 12 ILE A 127
MET A 257
LEU A 150
LEU A 143
ILE A 264
None
1.13A 1bsxA-2xt0A:
undetectable
1bsxA-2xt0A:
21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BSX_B_T3B2_1
(PROTEIN (THYROID
HORMONE RECEPTOR
BETA))
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
5 / 12 ILE A 127
MET A 257
LEU A 150
LEU A 143
ILE A 264
None
1.13A 1bsxB-2xt0A:
undetectable
1bsxB-2xt0A:
21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BXE_A_1FLA2001_1
(SERUM ALBUMIN)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
5 / 11 ILE A 213
ARG A 103
GLY A 222
LEU A 128
SER A 104
None
None
SO4  A1298 (-3.0A)
None
None
1.36A 2bxeA-2xt0A:
undetectable
2bxeA-2xt0A:
19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BXG_B_IBPB2001_1
(SERUM ALBUMIN)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
5 / 9 ILE A 213
ARG A 103
GLY A 222
LEU A 128
SER A 104
None
None
SO4  A1298 (-3.0A)
None
None
1.43A 2bxgB-2xt0A:
0.1
2bxgB-2xt0A:
19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C8A_D_NCAD1247_0
(MONO-ADP-RIBOSYLTRAN
SFERASE C3)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
4 / 7 ARG A 103
GLY A  99
SER A 104
PHE A 100
None
1.09A 2c8aD-2xt0A:
undetectable
2c8aD-2xt0A:
19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NNK_A_ROCA401_3
(PROTEASE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
6 / 12 LEU A 252
ASP A 123
GLY A  54
ILE A 183
PRO A 250
VAL A 251
None
1.48A 2nnkB-2xt0A:
undetectable
2nnkB-2xt0A:
18.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q63_A_1UNA1001_1
(PROTEASE RETROPEPSIN)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
6 / 12 LEU A 252
ASP A 123
GLY A  54
ILE A 183
PRO A 250
VAL A 251
None
1.49A 2q63A-2xt0A:
undetectable
2q63A-2xt0A:
16.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XCT_G_CPFG1020_1
(DNA GYRASE SUBUNIT
B, DNA GYRASE
SUBUNIT A)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
3 / 3 ARG A 209
GLY A 206
SER A 104
None
0.62A 2xctB-2xt0A:
1.9
2xctB-2xt0A:
16.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K4V_B_ROCB201_3
(HIV-1 PROTEASE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
6 / 12 LEU A 252
ASP A 123
GLY A  54
ILE A 183
PRO A 250
VAL A 251
None
1.45A 3k4vB-2xt0A:
undetectable
3k4vB-2xt0A:
14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDT_A_ROCA101_1
(PROTEASE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
6 / 12 LEU A 252
ASP A 123
GLY A  54
ILE A 183
PRO A 250
VAL A 251
None
1.46A 3ndtA-2xt0A:
undetectable
3ndtA-2xt0A:
14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDT_A_ROCA101_3
(PROTEASE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
6 / 12 LEU A 252
ASP A 123
GLY A  54
ILE A 183
PRO A 250
VAL A 251
None
1.45A 3ndtB-2xt0A:
undetectable
3ndtB-2xt0A:
14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDT_D_ROCD100_1
(PROTEASE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
6 / 12 LEU A 252
ASP A 123
GLY A  54
ILE A 183
PRO A 250
VAL A 251
None
1.42A 3ndtC-2xt0A:
undetectable
3ndtC-2xt0A:
14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDU_D_ROCD100_1
(PROTEASE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
6 / 12 LEU A 252
ASP A 123
GLY A  54
ILE A 183
PRO A 250
VAL A 251
None
1.43A 3nduC-2xt0A:
undetectable
3nduC-2xt0A:
14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TKG_B_ROCB801_2
(PROTEASE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
6 / 12 LEU A 252
ASP A 123
GLY A  54
ILE A 183
PRO A 250
VAL A 251
None
1.49A 3tkgB-2xt0A:
undetectable
3tkgB-2xt0A:
18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TL9_A_ROCA401_1
(PROTEASE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
6 / 12 LEU A 252
ASP A 123
GLY A  54
ILE A 183
PRO A 250
VAL A 251
None
1.48A 3tl9A-2xt0A:
undetectable
3tl9A-2xt0A:
18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V3O_B_T1CB405_1
(TETX2 PROTEIN)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
5 / 12 PHE A 100
GLY A  99
ALA A 205
GLY A 206
MET A   1
None
1.29A 3v3oB-2xt0A:
2.1
3v3oB-2xt0A:
21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FN9_B_STRB301_1
(STEROID RECEPTOR 2)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
5 / 12 LEU A 114
LEU A 109
LEU A 106
ALA A 107
MET A  35
None
1.23A 4fn9B-2xt0A:
undetectable
4fn9B-2xt0A:
20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LVC_A_ADNA501_2
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE
(SAHASE))
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
4 / 5 GLN A 236
THR A 235
THR A 241
LEU A 130
None
1.38A 4lvcA-2xt0A:
5.5
4lvcA-2xt0A:
23.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LVC_C_ADNC501_2
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE
(SAHASE))
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
4 / 5 GLN A 236
THR A 235
THR A 241
LEU A 130
None
1.37A 4lvcC-2xt0A:
undetectable
4lvcC-2xt0A:
23.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKV_D_AERD601_2
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
4 / 5 GLY A  54
ASP A 123
GLU A 282
VAL A 273
None
1.00A 4nkvD-2xt0A:
undetectable
4nkvD-2xt0A:
21.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UCK_B_SAMB2409_0
(RNA-DIRECTED RNA
POLYMERASE L)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
5 / 12 GLY A 157
GLY A 159
SER A 155
LEU A 154
ALA A 151
None
1.06A 4uckB-2xt0A:
undetectable
4uckB-2xt0A:
20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G5G_B_ACTB1321_0
(PUTATIVE XANTHINE
DEHYDROGENASE YAGR
MOLYBDENUM-BINDING
SU SUBUNIT)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
3 / 3 THR A 187
ASP A 188
ALA A 189
None
0.00A 5g5gB-2xt0A:
undetectable
5g5gB-2xt0A:
23.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
5 / 12 MET A  65
TYR A  62
GLN A 122
GLY A 246
VAL A 120
None
1.47A 5g6sB-2xt0A:
undetectable
5g6sC-2xt0A:
undetectable
5g6sB-2xt0A:
21.82
5g6sC-2xt0A:
21.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M5K_A_ADNA502_2
(ADENOSYLHOMOCYSTEINA
SE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
4 / 4 GLN A 236
THR A 235
THR A 241
LEU A 130
None
1.35A 5m5kA-2xt0A:
undetectable
5m5kA-2xt0A:
23.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M5K_C_ADNC502_2
(ADENOSYLHOMOCYSTEINA
SE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
4 / 4 GLN A 236
THR A 235
THR A 241
LEU A 130
None
1.34A 5m5kC-2xt0A:
2.5
5m5kC-2xt0A:
23.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M66_B_ADNB502_2
(ADENOSYLHOMOCYSTEINA
SE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
4 / 4 GLN A 236
THR A 235
THR A 241
LEU A 130
None
1.33A 5m66B-2xt0A:
4.5
5m66B-2xt0A:
23.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V5Z_A_1YNA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
5 / 12 PHE A 210
PHE A 100
GLY A  54
LEU A 105
PHE A  30
None
1.05A 5v5zA-2xt0A:
undetectable
5v5zA-2xt0A:
20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V5Z_A_1YNA602_2
(LANOSTEROL 14-ALPHA
DEMETHYLASE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
3 / 3 GLY A 246
THR A 187
PRO A 184
None
0.65A 5v5zA-2xt0A:
undetectable
5v5zA-2xt0A:
20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VYH_A_FOLA409_0
(S PROTEIN)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
5 / 10 ARG A  63
PRO A  18
GLY A 185
ILE A 186
ALA A 189
None
1.16A 5vyhA-2xt0A:
undetectable
5vyhA-2xt0A:
19.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BRD_B_RFPB502_1
(RIFAMPIN
MONOOXYGENASE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
5 / 12 MET A  65
VAL A 280
GLY A 126
GLY A 125
MET A 257
None
0.98A 6brdB-2xt0A:
undetectable
6brdB-2xt0A:
15.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ESM_A_PZEA307_1
(MATRIX
METALLOPROTEINASE-9,
MATRIX
METALLOPROTEINASE-9)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
3 / 3 TYR A  96
HIS A 101
PHE A  84
None
1.06A 6esmA-2xt0A:
undetectable
6esmA-2xt0A:
16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EXI_A_ADNA503_0
(ADENOSYLHOMOCYSTEINA
SE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
5 / 10 GLY A 239
VAL A 140
ASP A 141
THR A 241
ILE A 264
None
1.08A 6exiA-2xt0A:
5.5
6exiA-2xt0A:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EXI_B_ADNB503_1
(ADENOSYLHOMOCYSTEINA
SE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
5 / 10 GLY A 239
VAL A 140
ASP A 141
THR A 241
ILE A 264
None
1.05A 6exiB-2xt0A:
2.3
6exiB-2xt0A:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EXI_C_ADNC503_0
(ADENOSYLHOMOCYSTEINA
SE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
5 / 12 GLY A 239
VAL A 140
ASP A 141
THR A 241
ILE A 264
None
1.08A 6exiC-2xt0A:
2.3
6exiD-2xt0A:
2.8
6exiC-2xt0A:
20.93
6exiD-2xt0A:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EXI_D_ADND503_0
(ADENOSYLHOMOCYSTEINA
SE)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
5 / 12 GLY A 239
VAL A 140
ASP A 141
THR A 241
ILE A 264
None
1.07A 6exiC-2xt0A:
2.4
6exiD-2xt0A:
2.8
6exiC-2xt0A:
20.93
6exiD-2xt0A:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6F3M_B_ADNB502_2
(-)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
4 / 4 GLN A 236
THR A 235
THR A 241
LEU A 130
None
1.34A 6f3mB-2xt0A:
6.5
6f3mB-2xt0A:
19.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GBN_A_ADNA501_2
(-)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
4 / 5 GLN A 236
THR A 235
THR A 241
LEU A 130
None
1.38A 6gbnA-2xt0A:
undetectable
6gbnA-2xt0A:
23.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GBN_D_ADND501_2
(-)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
4 / 5 GLN A 236
THR A 235
THR A 241
LEU A 130
None
1.39A 6gbnD-2xt0A:
undetectable
6gbnD-2xt0A:
23.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NKN_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)
2xt0 HALOALKANE
DEHALOGENASE

(Plesiocystis
pacifica)
3 / 3 ARG A  10
PHE A  17
PHE A 198
SO4  A1300 (-2.7A)
None
None
1.00A 6nknC-2xt0A:
undetectable
6nknJ-2xt0A:
undetectable
6nknC-2xt0A:
21.23
6nknJ-2xt0A:
17.71